SEC Company Response from NANOVIRICIDES, INC. (NNVC) (CIK 0001379006) (NNVC) — Apr 5, 2007
NANOVIRICIDES, INC. (NNVC) (CIK 0001379006)
Date: April 5, 2007 · CIK: 0001379006 · Accession: 0001140361-07-007356
AI Filing Summary & Sentiment
Reasoning
Letter
VIA EDGAR ONLY Securities and Exchange Commission Attention: Suzanne Hayes, Esq. Re: NanoViricides, Inc. Form 10-SB, filed November 14, File No. 0-52318
Dear Ms. Hayes:
Please be advised that the undersigned is the duly elected Chief Executive Officer of NanoViricides, Inc. (the "Registrant"). Having been advised that the Commission has no further comments to the Registrant's Form 10-SB Registration Statement, the Registrant hereby requests acceleration of the effective date of the Registration Statement to Monday, April 8, 2007 at 9:30 a.m., or as soon thereafter as practicable.
Additionally, please note that the Registrant acknowledges the following:
·
should the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the filing;
·
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
·
the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States
Should you have any questions in regard to this correspondence or any other matter relating to this Registrant=s filing, please do not hesitate to contact the undersigned or the Registrant's counsel Peter Campitiello, Esq. at (212) 413-7427.
Very truly yours,
/s/ Eugene Seymour,
M.D.
Show Raw Text
CORRESP
1
filename1.htm
Nanoviricides Correspondence 4-5-2007
NANOVIRICIDES,
INC.
135
Wood
Street
Suite
205
West
Haven, Connecticut 06516
April
5, 2007
VIA
EDGAR ONLY
Securities
and Exchange Commission
100
F
Street, N.E.
Mail
Stop
6010
Washington,
D.C. 20549
Attention:
Suzanne Hayes, Esq.
Re:
NanoViricides, Inc.
Form 10-SB, filed November 14,
2006
File No.
0-52318
Dear
Ms.
Hayes:
Please
be
advised that the undersigned is the duly elected Chief Executive Officer of
NanoViricides, Inc. (the "Registrant"). Having been advised that the Commission
has no further comments to the Registrant's Form 10-SB Registration Statement,
the Registrant hereby requests acceleration of the effective date of the
Registration Statement to Monday, April 8, 2007 at 9:30 a.m., or as soon
thereafter as practicable.
Additionally,
please note that the Registrant acknowledges the following:
·
should
the Commission or the staff, acting pursuant to delegated authority,
declare the Registration Statement effective, it does not foreclose
the
Commission from taking any action with respect to the filing;
·
the
action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve
the
Registrant from its full responsibility for the adequacy and
accuracy of
the disclosure in the filing;
and
·
the
Registrant may not assert staff comments and the declaration
of
effectiveness as a defense in any proceeding initiated by the
Commission
or any person under the federal securities laws of the United
States
Should
you have any questions in regard to this correspondence or any other matter
relating to this Registrant=s
filing,
please do not hesitate to contact the undersigned or the Registrant's counsel
Peter Campitiello, Esq. at (212) 413-7427.
Very truly yours,
/s/ Eugene Seymour,
M.D.
Eugene Seymour,
M.D.